SEATTLE, November 24, 2025 — Leads & Copy — Sana Biotechnology, Inc. (NASDAQ: SANA) will webcast its presentations at two investor conferences in December, according to a press release issued today. The presentations will include a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer.
Sana Biotechnology, Inc. is focused on changing the possible for patients through engineered cells.
Sana will present at Citi’s 2025 Global Healthcare Conference at 2:30 p.m. ET on Tuesday, December 2, 2025. The company will also present at the 8th Annual Evercore Healthcare Conference at 2:35 p.m. ET on Wednesday, December 3, 2025.
The webcasts will be accessible on the Investor Relations page of Sana’s website at https://sana.com/. A replay of each presentation will be available at the same location for 30 days following the conference.
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients, sharing a vision of repairing and controlling genes, replacing missing or damaged cells, and making therapies broadly available to patients. Sana has operations in Seattle, WA, Cambridge, MA, and South San Francisco, CA.
Nicole Keith
investor.relations@sana.com
media@sana.com
Source: Sana Biotechnology
